GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID | UniProt ID | Title ▲ | Descriptor |
---|---|---|---|
1EN2 | 4138900 | UDA TETRASACCHARIDE COMPLEX. CRYSTAL STRUCTURE OF URTICA DIOICA AGGLUTININ, A SUPERANTIGEN PRESENTED BY MHC MOLECULES OF CLASS I AND CLASS II | |
1ENM | 4138900 | UDA TRISACCHARIDE COMPLEX. CRYSTAL STRUCTURE OF URTICA DIOICA AGGLUTININ, A SUPERANTIGEN PRESENTED BY MHC MOLECULES OF CLASS I AND CLASS II | |
5N2J | G0SB58 | UDP-Glucose Glycoprotein Glucosyltransferase from Chaetomium thermophilum (closed form) | UDP-glucose-glycoprotein glucosyltransferase-like protein |
5MZO | G0SB58 | UDP-Glucose Glycoprotein Glucosyltransferase from Chaetomium thermophilum (open conformation) | |
5NV4 | G0SB58 | UDP-Glucose Glycoprotein Glucosyltransferase from Chaetomium thermophilum double mutant D611C:G1050C | |
5MU1 | G0SB58 | UDP-Glucose Glycoprotein Glucosyltransferase from Chaetomium thermophilum soaked with K2PtI6 | |
2FV0 | Q9RC92 | UGL_D88N/dGlcA-Glc-Rha-Glc | |
2FV1 | Q9RC92 | UGL_D88N/dGlcA-GlcNAc | |
7LWS | P0DTC2 | UK (B.1.1.7) SARS-CoV-2 S-GSAS-D614G variant spike protein in the 3-RBD-down conformation | Spike glycoprotein |
7LWT | P0DTC2 | UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation | |
7LWU | P0DTC2 | UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation | |
7LWV | P0DTC2 | UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation | |
5COX | Q05769 | UNINHIBITED MOUSE CYCLOOXYGENASE-2 (PROSTAGLANDIN SYNTHASE-2) | |
1TLF | P03023 | UNPRECEDENTED QUATERNARY STRUCTURE OF E. COLI LAC REPRESSOR CORE TETRAMER: IMPLICATIONS FOR DNA LOOPING | |
1D2M | Q56243 | UVRB PROTEIN OF THERMUS THERMOPHILUS HB8; A NUCLEOTIDE EXCISION REPAIR ENZYME | |
4KV3 | P0AEX9 | Ubiquitin-like domain of the Mycobacterium tuberculosis type VII secretion system protein EccD1 as maltose-binding protein fusion | |
4KV3 | I6X8K0 | Ubiquitin-like domain of the Mycobacterium tuberculosis type VII secretion system protein EccD1 as maltose-binding protein fusion | |
5U3A | P04746 | Ultra High Resolution Crystal Structure of Human Pancreatic Alpha Amylase | |
7WS4 | P0DTC2 | Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants | |
7WS4 | 7WS4 | Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants | |
7E3L | P0DTC2 | Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants | |
7E3L | 7E3L | Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants | |
7E3K | P0DTC2 | Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants | |
7E3K | 7E3K | Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants | |
2IWA | O81226 | Unbound glutaminyl cyclotransferase from Carica papaya. | GLUTAMINE CYCLOTRANSFERASE (E.C.2.3.2.5) |
6ZGE | P0DTC2 | Uncleavable Spike Protein of SARS-CoV-2 in Closed Conformation | Spike glycoprotein |
5JSA | 5JSA | Uncleaved prefusion optimized gp140 trimer with an engineered 10-residue HR1 turn bound to broadly neutralizing antibodies 8ANC195 and PGT128 | |
5JS9 | 5JS9 | Uncleaved prefusion optimized gp140 trimer with an engineered 8-residue HR1 turn bound to broadly neutralizing antibodies 8ANC195 and PGT128 | |
6QVM | 6QVM | Undecaheme cytochrome from S-layer of Carboxydothermus ferrireducens | |
2WHL | Q5YEX6 | Understanding how diverse mannanases recognise heterogeneous substrates | |
6DM8 | P0AEX9 | Understanding the Species Selectivity of Myeloid cell leukemia-1 (Mcl-1) inhibitors | |
6DM8 | P97287 | Understanding the Species Selectivity of Myeloid cell leukemia-1 (Mcl-1) inhibitors | |
5N7B | P01727 | Understanding the singular conformational landscape of the Tn antigens: Sulfur-for- oxygen substitution in the glycosidic linkage provides new insights into molecular recognition by an antibody | |
5N7B | P01801 | Understanding the singular conformational landscape of the Tn antigens: Sulfur-for- oxygen substitution in the glycosidic linkage provides new insights into molecular recognition by an antibody | |
5N7B | 5N7B | Understanding the singular conformational landscape of the Tn antigens: Sulfur-for- oxygen substitution in the glycosidic linkage provides new insights into molecular recognition by an antibody | |
4UOI | H9XGD6 | Unexpected structure for the N-terminal domain of Hepatitis C virus envelope glycoprotein E1 | GENOME POLYPROTEIN |
3SGJ | P01857 | Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgIII and antibodies lacking core fucose | Fc fragment, human Fcg3a receptor |
3SGJ | P08637 | Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgIII and antibodies lacking core fucose | Fc fragment, human Fcg3a receptor |
3SGK | P01857 | Unique carbohydrate/carbohydrate interactions are required for high affinity binding of FcgIII and antibodies lacking core fucose | Fc fragment, human Fcg3a receptor |
3SGK | P08637 | Unique carbohydrate/carbohydrate interactions are required for high affinity binding of FcgIII and antibodies lacking core fucose | Fc fragment, human Fcg3a receptor |
4M7Z | 4M7Z | Unliganded 1 crystal structure of S25-26 Fab | S25-26 Fab (Igg1k) Heavy Chain, S25-26 Fab (Igg1k) Light Chain |
4M93 | 4M93 | Unliganded 2 crystal structure of S25-26 Fab | |
4MA1 | 4MA1 | Unliganded 3 crystal structure of S25-26 Fab | |
6TN1 | P04062 | Unliganded Crystal Structure of Recombinant GBA | |
6C5I | Q99LC4 | Unliganded S25-5 Fab | |
6C5I | 6C5I | Unliganded S25-5 Fab | |
6C5I | Q99LC4 | Unliganded S25-5 Fab | |
6C5I | 6C5I | Unliganded S25-5 Fab | |
6C5I | A0A0F7R5U8 | Unliganded S25-5 Fab | |
6C5I | A0A0F7R5U8 | Unliganded S25-5 Fab |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024